SRZN
Surrozen Inc
NASDAQ: SRZN · HEALTHCARE · BIOTECHNOLOGY
$31.56
+1.87% today
Updated 2026-04-29
Market cap
$371.23M
P/E ratio
—
P/S ratio
106.77x
EPS (TTM)
$-32.37
Dividend yield
—
52W range
$6 – $34
Volume
0.1M
Surrozen Inc (SRZN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-21.06M | $-29.10M | $-48.81M | $-44.15M | $-40.36M | $-17.63M | $-30.24M |
| Capital expenditures | $1.56M | $874000.00 | $1.27M | $728000.00 | $398000.00 | $26000.00 | $128000.00 |
| Depreciation | $2.28M | $1.94M | $2.07M | $1.96M | $1.91M | $1.44M | — |
| Stock-based comp | $790000.00 | $635000.00 | $2.32M | $4.52M | $4.37M | $4.11M | $3.83M |
| Free cash flow | $-22.62M | $-29.97M | $-50.08M | $-44.87M | $-40.76M | $-17.65M | $-30.37M |
| Investing cash flow | $-1.56M | $-15.07M | $-77.71M | $38.31M | $51.72M | $-26000.00 | — |
| Financing cash flow | $28.90M | $50.05M | $124.63M | $-2.56M | $276000.00 | $16.18M | — |
| Dividends paid | — | $48.39M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |